Hyper Insight™ – CTA 3D
Hyper Insight™ Stroke AI
One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.
Hyper Insight™ – CTA 3D
NCCT + CTAFDA & MFDS in ProgressPre-FDA Access
Fully automated, bone-subtracted 3D cerebrovascular reconstruction from non-contrast CT and CT angiography — results delivered to PACS in under 60 seconds, with no human intervention.
Capabilities
- Fully automated — no human intervention
- Under 60-second turnaround
- Automatic bone & vessel segmentation — full skull to clean vessel tree, interactive 360° rotation
- 3D vessel rendering (VR) through a translucent skull
- Multi-output rendering — VR / MIP / CPR
- 24/7 unattended operation
- PACS integration & mobile access
NCCTCTAAutomated Bone RemovalVessel Segmentation3D VR / MIP / CPRreport.dcm
3D Vessel Rendering (VR)
Bone-Removed Vessel Tree
Automated bone removal · full skull → clean vessel tree · interactive 360° rotation.
Performance & evidence
Under 60-second turnaround — bone removal → segmentation → reconstruction. Pipeline: NCCT + CTA input → VR / MIP / CPR outputs → report.dcm → PACS. Deployment: on-premise or cloud.
What it means clinically
- The technician’s manual reconstruction, delivered automatically in under a minute, 24/7 — replacing work that can take 10–20 minutes and sometimes hours.
- Clinical value: aneurysm morphology (neck, dome, orientation) — a direct enabler for CTA Aneurysm and for surgical and endovascular planning.
- Portfolio role: an enabler and add-on for Hyper Insight – CTA Infarct and Hyper Insight – CTA Aneurysm.